Brief: Seelos Therapeutics Inc says company Plans To Continue Its Previously Announced Potential Partnership Discussions
Jan 22 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS INC -PLANS TO CONTINUE ITS PREVIOUSLY
ANNOUNCED POTENTIAL PARTNERSHIP DISCUSSIONS
* SEELOS THERAPEUTICS INC -EXPECTS TO PROCEED TO PHASE III
WITH
SLS-002 IN ADULTS WITH MAJOR DEPRESSIVE DISORDER (MDD) AT
IMMINENT RISK OF SUICIDE
Source text for Eikon: ID:nPn8vfNQFa
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio